Compare ADMA Biologics Inc (ADMA) vs Public Storage (PSA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs Public Storage — how do they compare? ADMA Biologics Inc trades at $9.26 (market cap $2.13B), while Public Storage trades at $321.39 (market cap $57.71B). The key difference: Public Storage is far larger — about 27.1× ADMA Biologics Inc's market cap, and Public Storage pays a 3.65% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | PSA | |
|---|---|---|
Market Cap | $2.13B | $57.71B |
Sector | Health | Real Estate |
52-Week High | $20.38 | $329.64 |
52-Week Low | $7.60 | $258.44 |
Enterprise Value | $2.20B | $71.96B |
Dividend Yield | — | 3.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
Public Storage (PSA) trades at $328.69, near analyst consensus targets, with a slight 0.29% dip. The stock shows strong technical momentum with bullish moving averages and support at $321. Fundamentally, PSA maintains robust profitability with a 39.16% net margin and consistent earnings beats, though valuation multiples like P/E of 33.47 appear elevated. Recent developments include a $1.2B Canadian acquisition and enhanced liquidity facilities, signaling growth initiatives.
Outlook remains positive driven by operational strength and strategic expansions, but risks include high valuation sensitivity and interest rate exposure. Analyst consensus leans Hold (62.86%), with a $330.38 price target suggesting limited near-term upside. Investors should weigh solid fundamentals against premium pricing in a normalized REIT environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Public Storage
Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →
